Ramy Tadros - Mar 13, 2024 Form 4 Insider Report for METLIFE INC (MET)

Role: President, U.S. Business
Signature: /s/ Anna Nazarenko, Authorized Signer
Stock symbol: MET
Transactions as of: Mar 13, 2024
Transactions value $: -$289,479
Form type: 4
Date filed: 3/14/2024, 04:35 PM
Previous filing: Mar 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MET	Common Stock	Sale	-$289K	-4.03K	-2.67%	$71.90	147K	Mar 13, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023.
F2	The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $71.85 to $72.00, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.

Content

The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2023.

The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $71.85 to $72.00, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.